Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
Best Stocks To Watch: Two New IPOs, Pharma Titan AstraZeneca And Electrical Grid Play Emcor Trade Near Buy Points
09:43am, Tuesday, 07'th Oct 2025
The IPO sector, despite concerns that the federal government shutdown might negatively impact the debut of new companies, remains fertile ground for intrepid growth investors.
Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock
09:41am, Tuesday, 07'th Oct 2025
TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.
Baxdrostat met the primary endpoint in Bax24 Phase III trial in patients with resistant hypertension
07:00am, Tuesday, 07'th Oct 2025
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in a
AstraZeneca's baxdrostat hits key goal in major blood pressure trial
02:46am, Tuesday, 07'th Oct 2025
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) said its experimental drug baxdrostat met the main target in a late-stage study for patients with resistant hypertension. Specifically, it showed a “statistic
AstraZeneca's Baxdrostat meets main goal in high blood pressure study
02:14am, Tuesday, 07'th Oct 2025
AstraZeneca said on Tuesday its drug Baxdrostat met the main goal in a late-stage study in patients with treatment-resistant high blood pressure, or hypertension.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
AstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapies
08:04am, Monday, 06'th Oct 2025
Algen Biotechnologies said on Monday it has agreed to grant AstraZeneca a license to develop gene therapies the U.S.-based biotech discovers using its artificial intelligence-driven platform, in a dea
Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZeneca
08:00am, Monday, 06'th Oct 2025
SAN FRANCISCO--(BUSINESS WIRE)-- #AI--Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZeneca.
AstraZeneca inks $555 million gene-editing technology deal with Algen, FT reports
05:25am, Monday, 06'th Oct 2025
AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday.
AstraZeneca's Datroway boosts survival in advanced breast cancer trial
02:57am, Monday, 06'th Oct 2025
AstraZeneca said on Monday its precision drug Datroway improved overall survival and progression free survival in patients with an advanced form of breast cancer versus chemotherapy in a trial when gi
Astrazeneca (AZN) Rises Higher Than Market: Key Facts
07:16pm, Friday, 03'rd Oct 2025
Astrazeneca (AZN) closed at $85.31 in the latest trading session, marking a +1.98% move from the prior day.
Pharmaceutical Stocks: Valuations And Pipelines Are Only Beginning To Be Appreciated
04:20pm, Friday, 03'rd Oct 2025
Drug stocks are poised to outperform in 2025, driven by conservative valuations and a research renaissance in key therapeutic areas. US healthcare spending growth and transformative GLP-1 therapies, e
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
12:22pm, Thursday, 02'nd Oct 2025
Shares of AstraZeneca (AZN -0.84%) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results from a clinical study of Enhertu in treating HER2-positive early brea
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 02'nd Oct 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
10:59am, Wednesday, 01'st Oct 2025
WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub.
